Where Salivary nitric oxide is reported
Also listed as: Enterosalivary NO pathway
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| PACVS | ↓ reduced | healthy controls | Reduced NO bioavailability | Halma 2024 |
Frequently asked questions
In which conditions is Salivary nitric oxide altered?
In the OSMF atlas Salivary nitric oxide is reported in PACVS. It is reduced in 1 across 1 entries.
Is there a standard clinical test for Salivary nitric oxide?
The atlas entries for Salivary nitric oxide do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Salivary nitric oxide result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.